CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 211 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $5,000 | -98.6% | 275 | -98.3% | 0.00% | -100.0% |
| Q2 2021 | $351,000 | -53.3% | 15,975 | -49.4% | 0.01% | -50.0% |
| Q1 2021 | $751,000 | -8.3% | 31,575 | +0.9% | 0.01% | -20.0% |
| Q4 2020 | $819,000 | +50.3% | 31,300 | 0.0% | 0.02% | +25.0% |
| Q3 2020 | $545,000 | -29.6% | 31,300 | -32.0% | 0.01% | -33.3% |
| Q2 2020 | $774,000 | +21.9% | 46,000 | -13.9% | 0.02% | +5.9% |
| Q1 2020 | $635,000 | -1.7% | 53,400 | 0.0% | 0.02% | +30.8% |
| Q4 2019 | $646,000 | -14.4% | 53,400 | 0.0% | 0.01% | -13.3% |
| Q3 2019 | $755,000 | +51.9% | 53,400 | +19.7% | 0.02% | +50.0% |
| Q2 2019 | $497,000 | -5.2% | 44,600 | 0.0% | 0.01% | -9.1% |
| Q1 2019 | $524,000 | -57.1% | 44,600 | -50.0% | 0.01% | -21.4% |
| Q4 2018 | $1,221,000 | +95.4% | 89,200 | +100.0% | 0.01% | 0.0% |
| Q3 2018 | $625,000 | – | 44,600 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 5,188,417 | $85,349,000 | 7.80% |
| TANAKA CAPITAL MANAGEMENT INC | 144,602 | $2,379,000 | 5.69% |
| INGALLS & SNYDER LLC | 6,817,540 | $112,149,000 | 5.47% |
| NEXTHERA CAPITAL LP | 1,045,196 | $17,193,000 | 2.83% |
| Timpani Capital Management LLC | 245,279 | $4,035,000 | 1.41% |
| S&T BANK/PA | 426,257 | $7,012,000 | 1.25% |
| SHAKER INVESTMENTS LLC/OH | 107,670 | $1,771,000 | 1.10% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 434,624 | $7,150,000 | 0.94% |
| AMI ASSET MANAGEMENT CORP | 709,300 | $11,668,000 | 0.83% |
| Birchview Capital, LP | 75,500 | $1,242,000 | 0.82% |